The COVID Advisor

Please enjoy this continuing medical education lecture delivered at 40th Cellular Detoxification Conference sponsored by International College of Integrative Medicine in Indianapolis, Indianana, on September 7 2024. There are no medicine grand rounds or primary care conferences addressing this topic. It is a white space in medicine where no academic medical center has a fundamental approach to handling about 5-10% of the population suffering from post-acute sequalae after recurrent SARS-CoV-2 infection or COVID-19 infection. Both load the body with pathogenic Spike protein which incites inflammation, oxidative stress, coagulation, and all the downstream effects that result in symptoms. BSD=Base Spike Detoxification Because I have taken the ultimate accountability for McCullough Protocol Base Spike Detoxification (BSD) by publishing and copyrighting it in my own name, I can tell you first hand I get feedback about perceived safety and efficacy on a regular basis from all ove...

1. Yale News Article (February 19, 2025) Title: " Immune markers of post-vaccination syndrome indicate future research directions " Key Points: The article discusses a Yale study (published on medRxiv ) investigating post-vaccination syndrome (PVS), a condition where a small number of people report chronic symptoms after COVID-19 vaccination. The study included 42 participants with PVS and 22 healthy vaccinated controls, analyzing blood samples for immune markers. It notes that PVS is not officially recognized by medical authorities, and little is known about its biological basis. The study is framed as an initial step to characterize PVS, identifying potential immunological patterns that differ between PVS patients and controls. 2. MedPage Today Article (Feb 20, 2025) Title: " Researchers Describe Rare Syndrome After COVID Vaccine " Key Points: The article reports on the Yale study, specifically noting that detectable levels of the S1 subunit of the spike prote...

A Guide to Diagnosing and Managing Influenza and Respiratory Syncytial Virus (RSV) Infections in Adults In adult patients, COVID-19 (Omicron variant), influenza, and RSV present with similar symptoms and can, therefore, be difficult to distinguish. This guide aims to help diagnose and treat Influenza and Respiratory Syncytial Virus (RSV). Update: Added Minocycline (Jan 2023 update) For advice on how to protect yourself against infection, see  I-PREVENT: COVID, Flu and RSV Protection Protocol . For treatment of COVID-19, see  I-CARE: Early COVID Treatment Protocol . For treatment of Post Vaccine Complications, see I-RECOVER: Post Vaccine Treatment . Note that there are two I-Care Protocols; the I-Care Covid protocol to treat Covid and this protocol, I-Care Flu protocol.  About this Protocol The information in this document is our recommended approach to COVID-19 based on the best (and most recent) literature. It is provided as guidance to healthcare providers worldwide on...